https://www.selleckchem.com/pr....oducts/eeyarestatin-
a lack of studies in cardiovascular surgeries and in elderly populations who may be at increased risk for adverse events. The amount and certainty of evidence for the use of intravenous ketorolac as a treatment for postoperative pain varies across efficacy and safety outcomes and amongst comparators, from very low to moderate. The available evidence indicates that postoperative intravenous ketorolac administration may offer substantial pain relief for most patients, but further research may impact this estimate. Adverse events ap
Like
Comment
Share
